GEN Exclusives

More »

GEN News Highlights

More »
Nov 23, 2010

New Role Revealed for Cancer-Promoting Gene AEG-1 in Chemoresistance

  • Virginia Commonwealth University researchers claim the tumor-associated gene known as astrocyte elevated gene-1 (AEG-1) is also involved in protecting cancer cells from destruction by chemotherapy. They hope their findings, reported in the November 22 online early edition of PNAS, will mean that future technology capable of inhibiting or silencing the gene could help boost the effectiveness of treatments for aggressive tumors characterized by high expression of AEG-1.

    AEG-1 is already known to contribute directly to cancer cell survival, chemotherapeutic drug resistance, and tumor cell progression through its regulation of a number of intracellular processes, reports the VCU team, led by Paul B. Fisher, Ph.D., Thelma Newmeyer Corman endowed chair in cancer research at VCU Massey Cancer Center. The researchers’ newly reported study, however, has uncovered a previously unknown role for the gene in the regulation of protective autophagy, which prevents cancer cells from being destroyed by drugs or environmental attack. They claim this role played by AEG-1 may contribute to its tumor-promoting properties and identifies protective autophagy as a contributing factor in the gene’s chemoresistance activity.

    “Understanding how AEG-1 promotes resistance to chemotherapy and enhances cancer cell survival may lead to treatments that inhibit this gene and its regulated pathways, thereby uncovering potentially new therapeutic targets that can be exploited to enhance the ability of anticancer drugs to fight tumors,” Dr. Fisher claims. “The potential for translating these findings into beneficial approaches for patients is major, particularly for patients with aggressive cancers that are difficult to treat because of resistance to current therapies.”

Add a comment

  • You must be signed in to perform this action.
    Click here to Login or Register for free.
    You will be taken back to your selected item after Login/Registration.

Related content


GEN Jobs powered by connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
More »

Be sure to take the GEN Poll

Easing Restrictions for Terminal Patients

Should the Federal Government Pass a “Right to Try” Bill Allowing Terminally Ill Patients Access to Experimental Medicines?

More »